General Information of Drug Off-Target (DOT) (ID: OTAUFC2I)

DOT Name Nuclear pore complex-interacting protein family member A1 (NPIPA1)
Synonyms Nuclear pore complex-interacting protein; NPIP
Gene Name NPIPA1
Related Disease
Pseudoxanthoma elasticum ( )
UniProt ID
NPIA1_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Pfam ID
PF06409
Sequence
MFCCLGYEWLSGGCKTWHSAWVINTLADHRHRGTDFGGSPWLLIITVFLRSYKFAISLCT
SYLCVSFLKTIFPSQNGHDGSTDVQQRARRSNRRRQEGIKIVLEDIFTLWRQVETKVRAK
IRKMKVTTKVNRHDKINGKRKTAKEHLRKLSMKEREHGEKERQVSEAEENGKLDMKEIHT
YMEMFQRAQALRRRAEDYYRCKITPSARKPLCNRVRMAAVEHRHSSGLPYWPYLTAETLK
NRMGHQPPPPTQQHSIIDNSLSLKTPSECLLTPLPPSALPSADDNLKTPAECLLYPLPPS
ADDNLKTPPECLLTPLPPSAPPSVDDNLKTPPECVCSLPFHPQRMIISRN
Tissue Specificity Widely expressed.

Molecular Interaction Atlas (MIA) of This DOT

1 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Pseudoxanthoma elasticum DIS8WUQG Strong Genetic Variation [1]
------------------------------------------------------------------------------------
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
10 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Tretinoin DM49DUI Approved Tretinoin decreases the expression of Nuclear pore complex-interacting protein family member A1 (NPIPA1). [2]
Acetaminophen DMUIE76 Approved Acetaminophen increases the expression of Nuclear pore complex-interacting protein family member A1 (NPIPA1). [3]
Doxorubicin DMVP5YE Approved Doxorubicin decreases the expression of Nuclear pore complex-interacting protein family member A1 (NPIPA1). [4]
Cupric Sulfate DMP0NFQ Approved Cupric Sulfate increases the expression of Nuclear pore complex-interacting protein family member A1 (NPIPA1). [5]
Piroxicam DMTK234 Approved Piroxicam decreases the expression of Nuclear pore complex-interacting protein family member A1 (NPIPA1). [6]
Tamibarotene DM3G74J Phase 3 Tamibarotene decreases the expression of Nuclear pore complex-interacting protein family member A1 (NPIPA1). [2]
Genistein DM0JETC Phase 2/3 Genistein decreases the expression of Nuclear pore complex-interacting protein family member A1 (NPIPA1). [7]
Leflunomide DMR8ONJ Phase 1 Trial Leflunomide decreases the expression of Nuclear pore complex-interacting protein family member A1 (NPIPA1). [8]
Milchsaure DM462BT Investigative Milchsaure increases the expression of Nuclear pore complex-interacting protein family member A1 (NPIPA1). [9]
crotylaldehyde DMTWRQI Investigative crotylaldehyde decreases the expression of Nuclear pore complex-interacting protein family member A1 (NPIPA1). [10]
------------------------------------------------------------------------------------
⏷ Show the Full List of 10 Drug(s)

References

1 Identification of novel polymorphisms in the pM5 and MRP1 (ABCC1) genes at locus 16p13.1 and exclusion of both genes as responsible for pseudoxanthoma elasticum.Hum Mutat. 2001;17(1):74-5. doi: 10.1002/1098-1004(2001)17:1<74::AID-HUMU14>3.0.CO;2-F.
2 Differential modulation of PI3-kinase/Akt pathway during all-trans retinoic acid- and Am80-induced HL-60 cell differentiation revealed by DNA microarray analysis. Biochem Pharmacol. 2004 Dec 1;68(11):2177-86.
3 Multiple microRNAs function as self-protective modules in acetaminophen-induced hepatotoxicity in humans. Arch Toxicol. 2018 Feb;92(2):845-858.
4 Bringing in vitro analysis closer to in vivo: studying doxorubicin toxicity and associated mechanisms in 3D human microtissues with PBPK-based dose modelling. Toxicol Lett. 2018 Sep 15;294:184-192.
5 Physiological and toxicological transcriptome changes in HepG2 cells exposed to copper. Physiol Genomics. 2009 Aug 7;38(3):386-401.
6 Apoptosis induced by piroxicam plus cisplatin combined treatment is triggered by p21 in mesothelioma. PLoS One. 2011;6(8):e23569.
7 Changes in gene expressions elicited by physiological concentrations of genistein on human endometrial cancer cells. Mol Carcinog. 2006 Oct;45(10):752-63.
8 Endoplasmic reticulum stress and MAPK signaling pathway activation underlie leflunomide-induced toxicity in HepG2 Cells. Toxicology. 2017 Dec 1;392:11-21.
9 Transcriptional profiling of lactic acid treated reconstructed human epidermis reveals pathways underlying stinging and itch. Toxicol In Vitro. 2019 Jun;57:164-173.
10 Gene expression profile and cytotoxicity of human bronchial epithelial cells exposed to crotonaldehyde. Toxicol Lett. 2010 Aug 16;197(2):113-22.